Verified factor-similar pair

COWG vs PWB

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

UMD
Similarity score
82
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • COWG has the higher backtested relative Sharpe (1.243 vs 1.065).
  • COWG has the lower published fee (0.49% vs 0.55%).
  • COWG is cheaper on dividend valuation (97 vs 701, where 100 is each fund's historical median).
  • PWB has the stronger regression fit (adjusted R-squared 0.932 vs 0.759).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

COWG

Pacer US Large Cap Cash Cows Growth Leaders ETF
UMD
Adj. R2
0.759
Rel. Sharpe
1.243
Mkt beta
0.93
AUM
US$2.1B
MER
0.49%
Valuation
97

PWB

Invesco Large Cap Growth ETF
UMD
Adj. R2
0.932
Rel. Sharpe
1.065
Mkt beta
1.08
AUM
US$1.7B
MER
0.55%
Valuation
701

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
COWG
+0.10
|t|
+0.6
PWB
-0.08
|t|
-2.3
diff +0.17
HML
COWG
-0.10
|t|
-0.6
PWB
-0.19
|t|
-5.7
diff +0.09
RMW
COWG
-0.18
|t|
-1.2
PWB
-0.11
|t|
-2.6
diff -0.07
CMA
COWG
+0.11
|t|
+0.5
PWB
-0.01
|t|
-0.2
diff +0.12
UMD
COWG
+0.19
|t|
+2.0
PWB
+0.17
|t|
+8.6
diff +0.02

Why This Pair Matches

Exposure level
84
Exposure shape
85
Mkt beta diff
0.15
Rel. Sharpe diff
0.178

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

COWG fund page PWB fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.